GHK (Glycyl-L-histidyl-L-lysine) — Peptide Encyclopedia | RetatrutideCompare

Binds copper(II) with high affinity; modulates ~4,000 human genes related to wound healing, ECM remodeling, anti-inflammation, and DNA repair.

Reference facts

Also known as
Glycyl-L-histidyl-L-lysine
Category
Healing & Tissue Repair
Mechanism of action
Binds copper(II) with high affinity; modulates ~4,000 human genes related to wound healing, ECM remodeling, anti-inflammation, and DNA repair.
Targets
Cu²⁺ chelation, Decorin, integrin, MMP gene expression
Indications under research or approved
Cosmetic / wound healing (research)
Regulatory status (reference entry)
Cosmetic ingredient; not FDA-approved as drug
Half-life
minutes (rapid plasma clearance)
Sequence
GHK
Sequence notes
Tripeptide naturally present in plasma (~200 μg/L at age 20, declines with age).
Molecular weight (Da)
340
First reported
1973
Origin
Discovered by Loren Pickart in human plasma fraction.

Primary References

Explore research articles about GHK

This is an educational reference, not medical advice. Research findings do not establish safety or efficacy for self-administration. Consult the primary sources for study populations, limitations, and current regulatory status.